B. Xing

Anisomycin induces glioma cell death via down-regulation of PP2A catalytic subunit in vitro

M. Li, Jun-yang Li, Jia-yuan Huang, 2012, Acta Pharmacologica Sinica.

Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.

M. Dimopoulos, A. Palumbo, A. Jakubowiak, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical utility and effectiveness of a training programme in the application of a new classification of narrow‐band imaging for vocal cord leukoplakia: A multicentre study

X. Ni, Gui-qi Wang, B. Xing, 2019, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

Biomarkers of treatment benefit in a randomized phase II study of bevacizumab in combination with carboplatin and paclitaxel in metastatic melanoma patients (BEAM).

P. Hegde, Kevin B. Kim, S. O’Day, 2010 .

A phase Ia/Ib trial of the anti-programmed death-ligand 1 (PD-L1) human monoclonal antibody (mAb), CS1001, in patients (pts) with advanced solid tumours or lymphomas

Yu Wang, Jin Li, J. Li, 2019, Annals of Oncology.

Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.

R. Janssen, Darren K Mcguire, R. Hyer, 2018, Vaccine.

938P KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in combination with lenvatinib in the treatment for advanced unresectable or metastatic hepatocellular carcinoma (HCC): Preliminary efficacy and safety results of a prospective phase II trial

B. Xing, 2021, Annals of Oncology.

Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.

Michael L. Wang, M. Dimopoulos, A. Palumbo, 2015, The New England journal of medicine.

t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65

M. Li, Hongyi Liu, Jun-yang Li, 2012, Journal of Neuro-Oncology.

The efficacy of cisplatin and low-temperature plasma radiofrequency ablation in advanced laryngeal cancer patients and on the serum survivin levels.

B. Xing, Guoli Li, B. Dai, 2021, American journal of translational research.

The effects of albumin-bound paclitaxel combined with cisplatin injections on patients with advanced laryngeal cancer and serum survivin.

B. Xing, Guoli Li, B. Dai, 2021, American journal of translational research.

Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.

R. Janssen, A. Ribas, G. Daniels, 2018, Journal of Clinical Oncology.

SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest.

Jing Li, W. Hu, M. Li, 2012, Die Pharmazie.